Effects of apomorphine on central serotonergic system

Effects of apomorphine on central serotonergic system

Show other versions (2)

碩士 === 國立政治大學 === 心理研究所 === 73 ===

Bibliographic Details
Main Authors:	Wang, Feng-Bin, 王豐彬
Other Authors:	Li, Xiao-Yuan
Format:	Others
Language:	zh-TW
Published:	1985
Online Access:	http://ndltd.ncl.edu.tw/handle/33155345261383206250

Similar Items

Apomorphine effects on the hippocampus
by: Luis Enrique Arroyo-Garcia, et al.
Published: (2018-01-01)

Effects of Apomorphine on the Activity of Neuron
by: Wen-Chuan Hsiao, et al.
Published: (2002)

Genotoxic, neurotoxic and neuroprotective activities of apomorphine and its oxidized derivative 8-oxo-apomorphine
by: J.N. Picada, et al.
Published: (2005-04-01)

Lipid nanoparticles as drug delivery systems for apomorphine
by: Hui Wen Chang, et al.
Published: (2010)

Population pharmacokinetic analysis of apomorphine sublingual film or subcutaneous apomorphine in healthy subjects and patients with Parkinson’s disease
by: Felix Agbo, et al.
Published: (2021-07-01)

Apomorphine in Parkinson's disease—The questions raised
by: Rajinder K Dhamija, et al.
Published: (2020-01-01)

Looking beyond the fog—apomorphine demystified
by: L K Prashanth, et al.
Published: (2020-01-01)

The Pharmacological Properties and Therapeutic Use of Apomorphine
by: Samo Ribarič
Published: (2012-05-01)

controlled apomorphine delivery system based on thermosensitive biodegradable hydrogel
by: Yi-Xiu Chen, et al.
Published: (2005)

Development and evaluation of drug delivery systems for apomorphine and its prodrugs
by: Ming Chuan Ku, et al.
Published: (2011)

Continuous subcutaneous apomorphine monotherapy in Parkinson’s disease
by: Ewa Papuć, et al.
Published: (2019-03-01)

Apomorphine in the treatment of Parkinson's disease: a review
by: Renata Ramina Pessoa, et al.

Apomorphine Targets the Pleiotropic Bacterial Regulator Hfq
by: Florian Turbant, et al.
Published: (2021-03-01)

Study of apomorphine-loaded microemulsions for transdermal drug delivery
by: Yi-Cheng Chen, et al.
Published: (2014)

Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease
by: Nrupa Borkar, et al.
Published: (2018-11-01)

Au nanoparticle-based sensor for apomorphine detection in plasma
by: Chiara Zanchi, et al.
Published: (2015-11-01)

Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
by: Angelo Antonini
Published: (2009-05-01)

Stability of apomorphine in solutions containing selected antioxidant agents
by: Ang ZY, et al.
Published: (2016-10-01)

A pharmacological investigation of apomorphine hydrochloride and of thebaine hydrochloride
by: Raftery, J. Delamere
Published: (1934)

A Method for Quantifying the Effects of Apomorphine Upon the Gnawing Syndrome of the Rat
by: Robinson, Paul
Published: (1967)

Effects of harmane, norharmane and harmine on apomorphine-induced pecking behavior in chick
by: Davood Farzin, et al.
Published: (2009-01-01)

Inhibitory Effect of Apomorphine on Focal and Nonfocal Plasticity in the Human Motor Cortex
by: Shane M. Fresnoza, et al.
Published: (2021-05-01)

Interaction between central cannabinergic and serotonergic systems in the rat
by: Overbury, Alison L.
Published: (2004)

Subset specification of central serotonergic neurons
by: Marten P Smidt, et al.
Published: (2013-10-01)

Central serotonergic control of cardiovascular reflexes
by: Kellett, Daniel Otto
Published: (2005)

The effects of female sex steroids on central serotonergic neurotransmission
by: Shanks, Elaine Anne
Published: (1999)

Development of the solid lipid nanoparticle formulation of apomorphine for oral delivery
by: Yao-Jen Kao, et al.
Published: (2008)

Investigation of apomorphine during sleep in Parkinson’s: Improvement in UPDRS Scores
by: Miguel A. Pieroni
Published: (2019-12-01)

Apomorphine: The initial indian experience in relation to response tests and pumps
by: L K Prashanth, et al.
Published: (2020-01-01)

Relationship of Dopamine of the Nucleus Accumbens with Intra-infralimbic Apomorphine Microinjection
by: Abbas Alimoradian, et al.
Published: (2013-06-01)

Prevention of medication errors in healthcare transition of patients treated with apomorphine
by: M. Ucha Sanmartin, et al.
Published: (2014-05-01)

Pharmacokinetic and pharmcodynamic studies of apomorphine in the treatment of idiopathic Parkinson's disease
by: Ingram, Wendy Merewyn
Published: (2001)

Differential effects of serotonin antagonists on hypothermia and stereotyped behavior induced by apomorphine and lergotrile in rats
by: Wade, Rolin Lee
Published: (1980)

Dopamine transporter genotype dependent effects of apomorphine on cold pain tolerance in healthy volunteers.
by: Roi Treister, et al.
Published: (2013-01-01)

Zonisamide Enhances Motor Effects of Levodopa, Not of Apomorphine, in a Rat Model of Parkinson’s Disease
by: Haruo Nishijima, et al.
Published: (2018-01-01)

The effect of apomorphine on anodal tDCS-induced cortical plasticity in the human motor cortex
by: Mueller, Lynn Elena
Published: (2018)

Subcutaneous apomorphine in advanced Parkinson’s disease and its use in Indian population
by: Vinod Metta, et al.
Published: (2020-01-01)

Turmeric active substance, curcumin, enhanced apomorphine-induced yawning in rats
by: Esmaeal Tamaddonfard
Published: (2013-05-01)

Validations of apomorphine-induced BOLD activation correlations in hemiparkinsonian rhesus macaques
by: J.E. Quintero, et al.
Published: (2019-01-01)

Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging
by: Wen CJ, et al.
Published: (2012-03-01)